Jennes L, Stumpf W E, Conn P M
Endocrinology. 1983 Nov;113(5):1683-9. doi: 10.1210/endo-113-5-1683.
A metabolically stable GnRH agonist (D-Lys6-GnRH) has been coupled to electron-opaque markers (colloidal gold and ferritin) to characterize the intracellular pathway of the releasing hormone bound by pituitary gonadotropes. This approach has the advantage of increasing the resolution of localization to a "circle of uncertainty" about 10- to 20-fold smaller than that which can be obtained by autoradiography. After an initial uniform distribution on the cell surface, the derivatives were taken up individually as well as in small clusters in coated and uncoated membrane invaginations and moved to the lysosomal compartment either directly or after passage through the Golgi apparatus. The results suggest that labeled GnRH or GnRH-receptor complex may be routed to two distinct intracellular compartments: the lysosome and the Golgi cisternae. It is unclear whether each releasing hormone-marker conjugate must be transported through both compartments before degradation.
一种代谢稳定的促性腺激素释放激素激动剂(D-赖氨酸6-促性腺激素释放激素)已与电子不透明标记物(胶体金和铁蛋白)偶联,以表征垂体促性腺细胞结合的释放激素的细胞内途径。这种方法的优点是将定位分辨率提高到比放射自显影所能获得的“不确定圈”小约10至20倍。在细胞表面最初均匀分布后,这些衍生物以单个以及小簇的形式被摄取到有被和无被膜内陷中,并直接或在通过高尔基体后转移到溶酶体区室。结果表明,标记的促性腺激素释放激素或促性腺激素释放激素-受体复合物可能被输送到两个不同的细胞内区室:溶酶体和高尔基池。目前尚不清楚每种释放激素-标记物缀合物在降解之前是否必须通过这两个区室进行运输。